News

Filter

Current filters:

Cell TherapeuticsOncology

1 to 9 of 27 results

Cell Thera’s NHL drug Pixuvri gets backing from UK’s NICE

27-02-2014

US biotech firm Cell Therapeutics has received positive news from the UK’s drugs watchdog for use of…

BiotechnologyCell TherapeuticsNorthern EuropeOncologyPixuvriPricingRegulationUK

Cell Therapeutics to reacquire rights to two anti-cancer compounds

13-01-2014

US biotech firm Cell Therapeutics says it has reached an agreement with partner Novartis to reacquire…

BiotechnologyCell TherapeuticsLicensingNovartisOncologyOpaxioPixuvri

FDA lifts partial clinical hold on Cell Therapeutics’ tosedostat

FDA lifts partial clinical hold on Cell Therapeutics’ tosedostat

02-01-2014

US biotech firm Cell Therapeutics has received notification from the US Food and Drug Administration…

BiotechnologyCell TherapeuticsNorth AmericaOncologyRegulationtosedostatUSA

UK’s NICE says yes to Cell Thera’s non-Hodgkin’s lymphoma drug Pixuvri

UK’s NICE says yes to Cell Thera’s non-Hodgkin’s lymphoma drug Pixuvri

31-12-2013

US biotech firm Cell Therapeutics’ Pixuvri (pixantrone), a treatment for an aggressive type of cancer…

BiotechnologyCell TherapeuticsEuropeOncologyPixuvriPricingRegulation

Cell Therapeutics reaches price deal with German insurer GKV-SV on Pixuvri

Cell Therapeutics reaches price deal with German insurer GKV-SV on Pixuvri

04-12-2013

US biotech firm Cell Therapeutics has concluded an agreement with the Germany’s National Association…

BiotechnologyCell TherapeuticsOncologyPixuvriPricingRare diseases

Baxter buys exclusive rights to CTI’s cancer drug pacritinib

18-11-2013

USA-based companies Baxter International and Cell Therapeutics have entered into an exclusive worldwide…

Baxter InternationalCell TherapeuticsFinancialGlobalLicensingOncologypacritinibPharmaceutical

UK’s NICE reconsiders backing for lymphoma drug Pixuvri

15-10-2013

The UK's National Institute for Health and Care Excellence has launched a second consultation on draft…

Cell TherapeuticsEuropeOncologyPharmaceuticalPixuvriPricingRegulation

Non-Hodgkin lymphoma treatment Pixuvri given market access in France

19-08-2013

USA-based Cell Therapeutics (Nasdaq: CTIC) has been granted market access in France for its aggressive…

Cell TherapeuticsEuropeOncologyPharmaceuticalPixuvriRegulation

1 to 9 of 27 results

COMPANY SPOTLIGHT

Menarini

Back to top